Bone Density Decline: Tenofovir has been associated with a lower in bone mineral density, raising the potential risk of bone complications or fractures. In stage 3 medical trials, tenofovir presented an analogous efficacy than efavirenz in cure-naive HIV sufferers. In hepatitis B contaminated patients, immediately after a single calendar year https://hivhub.in/product/viropil-tablet/